DEspR
Dual endothelin-1/VEGFsp receptor (DEspR) is a common target on tumor vascular endothelial cells (TVECs), tumor cells (TCs), and cancer stem cells (CSCs) in glioblastoma and pancreatic cancer. It's inhibition provides a potential therapeutic strategy for simultaneous inhibition of multiple pro-malignancy steps: angiogenesis, invasiveness, and anoikis resistance.
Species Reactivity: Human
Compare
Type: Humanized antibody
Application: IHC, ELISA
Compare
Species Reactivity: Human
Compare
Species Reactivity: Human
Type: ADCC enhanced antibody
Compare
Species Reactivity: Human
Type: Human scFv
Application: ELISA, FC, Inhib, WB, IF
Compare
Type: Humanized antibody
Application: FC, FuncS, Inhib
Compare
Species Reactivity: Human
Type: Human Fab
Application: ELISA, FC, Inhib, WB, IF
Compare
Application: FC, FuncS, Inhib
Compare
Species Reactivity: Human
Type: Human scFv
Application: ELISA, FC, Inhib, WB, IF
Compare
Species Reactivity: Human
Type: Human Fab
Application: ELISA, FC, Inhib, WB, IF
Compare
Species Reactivity: Human
Type: Human IgG
Application: ELISA, FC, Inhib, WB, IF
Compare
Type: Humanized antibody
Application: IHC, ELISA
Compare
Species Reactivity: Human
Type: Human IgG
Application: ELISA, FC, Inhib, WB, IF
Compare
Species Reactivity: Human
Type: Antibody
Compare
Species Reactivity: Human
Type: Human scFv
Application: ELISA, FC, Inhib, WB, IF
Compare
Species Reactivity: Human
Type: Human Fab
Application: ELISA, FC, Inhib, WB, IF
Compare
Species Reactivity: Human
Type: Human IgG
Application: ELISA, FC, Inhib, WB, IF
Compare
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
For Research Use Only. Not For Clinical Use.